Is neoadjuvant chemotherapy followed by surgery the appropriate treatment for esophagogastric signet ring cell carcinomas?: a systematic review and meta-analysis

<sec><title>Background</title><p>The impact of neoadjuvant chemotherapy (nCTX) on survival and tumor response in patients with esophagogastric signet ring cell carcinoma (SRCC) is still controversial.</p></sec><sec><title>Methods</title><p>...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schiefer, Sabine (VerfasserIn) , Crnovrsanin, Nerma (VerfasserIn) , Kalkum, Eva (VerfasserIn) , Vey, Johannes (VerfasserIn) , Nienhüser, Henrik (VerfasserIn) , Rompen, Ingmar F. (VerfasserIn) , Haag, Georg Martin (VerfasserIn) , Müller, Beat P. (VerfasserIn) , Billmann, Franck (VerfasserIn) , Schmidt, Thomas (VerfasserIn) , Probst, Pascal (VerfasserIn) , Klotz, Rosa (VerfasserIn) , Peters, Leila (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 06 May 2024
In: Frontiers in Surgery
Year: 2024, Jahrgang: 11, Pages: 1-11
ISSN:2296-875X
DOI:10.3389/fsurg.2024.1382039
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fsurg.2024.1382039
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2024.1382039/full
Volltext
Verfasserangaben:Sabine Schiefer, Nerma Crnovrsanin, Eva Kalkum, Johannes A. Vey, Henrik Nienhüser, Ingmar F. Rompen, Georg M. Haag, Beat Müller-Stich, Franck Billmann, Thomas Schmidt, Pascal Probst, Rosa Klotz and Leila Sisic

MARC

LEADER 00000caa a2200000 c 4500
001 1908109394
003 DE-627
005 20241205185300.0
007 cr uuu---uuuuu
008 241109s2024 xx |||||o 00| ||eng c
024 7 |a 10.3389/fsurg.2024.1382039  |2 doi 
035 |a (DE-627)1908109394 
035 |a (DE-599)KXP1908109394 
035 |a (OCoLC)1475637774 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schiefer, Sabine  |e VerfasserIn  |0 (DE-588)1255009969  |0 (DE-627)1797787284  |4 aut 
245 1 0 |a Is neoadjuvant chemotherapy followed by surgery the appropriate treatment for esophagogastric signet ring cell carcinomas?  |b a systematic review and meta-analysis  |c Sabine Schiefer, Nerma Crnovrsanin, Eva Kalkum, Johannes A. Vey, Henrik Nienhüser, Ingmar F. Rompen, Georg M. Haag, Beat Müller-Stich, Franck Billmann, Thomas Schmidt, Pascal Probst, Rosa Klotz and Leila Sisic 
264 1 |c 06 May 2024 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.11.2024 
520 |a <sec><title>Background</title><p>The impact of neoadjuvant chemotherapy (nCTX) on survival and tumor response in patients with esophagogastric signet ring cell carcinoma (SRCC) is still controversial.</p></sec><sec><title>Methods</title><p>Two independent reviewers performed a systematic literature search in Medline, CENTRAL, and Web of Science including prospective and retrospective two-arm non-randomized and randomized controlled studies (RCTs). Data was extracted on overall survival (OS) and tumor regression in resected esophagogastric SRCC patients with or without nCTX. Survival data was analyzed using published hazard ratios (HR) if available or determined it from other survival data or survival curves. OS and histopathological response rates by type of tumor (SRCC vs. non-SRCC) were also investigated.</p></sec><sec><title>Results</title><p>Out of 559 studies, ten (1 RCT, 9 non-RCTs) were included in this meta-analysis (PROSPERO CRD42022298743) investigating 3,653 patients in total. The four studies investigating survival in SRCC patients treated with nCTX + surgery vs. surgery alone showed no survival benefit for neither intervention, but heterogeneity was considerable (HR, 1.01; 95% CI, 0.61-1.67; <italic>p</italic> = 0.98; <italic>I</italic><sup>2 </sup>= 89%). In patients treated by nCTX + surgery SRCC patients showed worse survival (HR, 1.45; 95% CI, 1.21-1.74; <italic>p</italic> < 0.01) and lower rate of major histopathological response than non-SRCC patients (OR, 2.47; 95% CI, 1.78-3.44; <italic>p</italic> < 0.01).</p></sec><sec><title>Conclusion</title><p>The current meta-analysis could not demonstrate beneficial effects of nCTX for SRCC patients. Histopathological response to and survival benefits of non-taxane-based nCTX seem to be lower in comparison to non-SRC esophagogastric cancer. However, certainty of evidence is low due to the scarcity of high-quality trials. Further research is necessary to determine optimal treatment for SRCC patients.</p></sec><sec><title>Systematic Review Registration</title><p><ext-link ext-link-type="uri" xlink:href="https://www.crd.york.ac.uk/" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.crd.york.ac.uk/</ext-link>, PROSPERO (CRD42022298743).</p></sec> 
650 4 |a Esophagogastric cancer 
650 4 |a esophagogastric neoplasm 
650 4 |a Meta-analysis 
650 4 |a Neoadjuvant chemotherapy 
650 4 |a Signet ring cell carcinoma 
650 4 |a SRCC 
650 4 |a Systematic review 
700 1 |a Crnovrsanin, Nerma  |e VerfasserIn  |0 (DE-588)1224835220  |0 (DE-627)174431442X  |4 aut 
700 1 |a Kalkum, Eva  |d 1982-  |e VerfasserIn  |0 (DE-588)1123754128  |0 (DE-627)877413673  |0 (DE-576)482124547  |4 aut 
700 1 |a Vey, Johannes  |e VerfasserIn  |0 (DE-588)1202625274  |0 (DE-627)1687019436  |4 aut 
700 1 |a Nienhüser, Henrik  |d 1986-  |e VerfasserIn  |0 (DE-588)104690342X  |0 (DE-627)777295865  |0 (DE-576)398176477  |4 aut 
700 1 |a Rompen, Ingmar F.  |d 1994-  |e VerfasserIn  |0 (DE-588)1260414086  |0 (DE-627)1807281671  |4 aut 
700 1 |a Haag, Georg Martin  |d 1979-  |e VerfasserIn  |0 (DE-588)133390934  |0 (DE-627)544043863  |0 (DE-576)29981548X  |4 aut 
700 1 |a Müller, Beat P.  |d 1971-  |e VerfasserIn  |0 (DE-588)14066209X  |0 (DE-627)70374819X  |0 (DE-576)317992287  |4 aut 
700 1 |a Billmann, Franck  |d 1977-  |e VerfasserIn  |0 (DE-588)13744902X  |0 (DE-627)695823655  |0 (DE-576)303567651  |4 aut 
700 1 |a Schmidt, Thomas  |d 1980-  |e VerfasserIn  |0 (DE-588)132383152  |0 (DE-627)521950023  |0 (DE-576)260799149  |4 aut 
700 1 |a Probst, Pascal  |d 1980-  |e VerfasserIn  |0 (DE-588)1071577204  |0 (DE-627)826053572  |0 (DE-576)43316283X  |4 aut 
700 1 |a Klotz, Rosa  |d 1987-  |e VerfasserIn  |0 (DE-588)1071554808  |0 (DE-627)826037410  |0 (DE-576)433145870  |4 aut 
700 1 |a Peters, Leila  |d 1982-  |e VerfasserIn  |0 (DE-588)1031408770  |0 (DE-627)736378405  |0 (DE-576)378855654  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in Surgery  |d Lausanne : Frontiers Media, 2014  |g 11(2024) vom: 6. Mai, Artikel-ID 1382039, Seite 1-11  |h Online-Ressource  |w (DE-627)788288954  |w (DE-600)2773823-1  |w (DE-576)408066717  |x 2296-875X  |7 nnas  |a Is neoadjuvant chemotherapy followed by surgery the appropriate treatment for esophagogastric signet ring cell carcinomas? a systematic review and meta-analysis 
773 1 8 |g volume:11  |g year:2024  |g day:6  |g month:05  |g elocationid:1382039  |g pages:1-11  |g extent:11  |a Is neoadjuvant chemotherapy followed by surgery the appropriate treatment for esophagogastric signet ring cell carcinomas? a systematic review and meta-analysis 
856 4 0 |u https://doi.org/10.3389/fsurg.2024.1382039  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2024.1382039/full  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20241109 
993 |a Article 
994 |a 2024 
998 |g 1031408770  |a Peters, Leila  |m 1031408770:Peters, Leila  |d 910000  |d 910200  |d 50000  |e 910000PP1031408770  |e 910200PP1031408770  |e 50000PP1031408770  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 13  |y j 
998 |g 1071554808  |a Klotz, Rosa  |m 1071554808:Klotz, Rosa  |d 910000  |d 910200  |d 50000  |e 910000PK1071554808  |e 910200PK1071554808  |e 50000PK1071554808  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 12 
998 |g 1071577204  |a Probst, Pascal  |m 1071577204:Probst, Pascal  |d 50000  |e 50000PP1071577204  |k 0/50000/  |p 11 
998 |g 132383152  |a Schmidt, Thomas  |m 132383152:Schmidt, Thomas  |d 50000  |e 50000PS132383152  |k 0/50000/  |p 10 
998 |g 13744902X  |a Billmann, Franck  |m 13744902X:Billmann, Franck  |d 910000  |d 910200  |d 50000  |e 910000PB13744902X  |e 910200PB13744902X  |e 50000PB13744902X  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 9 
998 |g 14066209X  |a Müller, Beat P.  |m 14066209X:Müller, Beat P.  |d 50000  |e 50000PM14066209X  |k 0/50000/  |p 8 
998 |g 133390934  |a Haag, Georg Martin  |m 133390934:Haag, Georg Martin  |d 910000  |d 910100  |d 50000  |e 910000PH133390934  |e 910100PH133390934  |e 50000PH133390934  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 7 
998 |g 1260414086  |a Rompen, Ingmar F.  |m 1260414086:Rompen, Ingmar F.  |d 910000  |d 910200  |e 910000PR1260414086  |e 910200PR1260414086  |k 0/910000/  |k 1/910000/910200/  |p 6 
998 |g 104690342X  |a Nienhüser, Henrik  |m 104690342X:Nienhüser, Henrik  |d 910000  |d 910200  |e 910000PN104690342X  |e 910200PN104690342X  |k 0/910000/  |k 1/910000/910200/  |p 5 
998 |g 1202625274  |a Vey, Johannes  |m 1202625274:Vey, Johannes  |d 910000  |d 911800  |e 910000PV1202625274  |e 911800PV1202625274  |k 0/910000/  |k 1/910000/911800/  |p 4 
998 |g 1123754128  |a Kalkum, Eva  |m 1123754128:Kalkum, Eva  |d 910000  |d 910200  |e 910000PK1123754128  |e 910200PK1123754128  |k 0/910000/  |k 1/910000/910200/  |p 3 
998 |g 1224835220  |a Crnovrsanin, Nerma  |m 1224835220:Crnovrsanin, Nerma  |d 910000  |d 910200  |e 910000PC1224835220  |e 910200PC1224835220  |k 0/910000/  |k 1/910000/910200/  |p 2 
999 |a KXP-PPN1908109394  |e 461269161X 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Sabine Schiefer, Nerma Crnovrsanin, Eva Kalkum, Johannes A. Vey, Henrik Nienhüser, Ingmar F. Rompen, Georg M. Haag, Beat Müller-Stich, Franck Billmann, Thomas Schmidt, Pascal Probst, Rosa Klotz and Leila Sisic"]},"language":["eng"],"id":{"eki":["1908109394"],"doi":["10.3389/fsurg.2024.1382039"]},"physDesc":[{"extent":"11 S."}],"title":[{"title_sort":"Is neoadjuvant chemotherapy followed by surgery the appropriate treatment for esophagogastric signet ring cell carcinomas?","subtitle":"a systematic review and meta-analysis","title":"Is neoadjuvant chemotherapy followed by surgery the appropriate treatment for esophagogastric signet ring cell carcinomas?"}],"person":[{"display":"Schiefer, Sabine","given":"Sabine","role":"aut","family":"Schiefer"},{"given":"Nerma","display":"Crnovrsanin, Nerma","role":"aut","family":"Crnovrsanin"},{"role":"aut","given":"Eva","display":"Kalkum, Eva","family":"Kalkum"},{"role":"aut","given":"Johannes","display":"Vey, Johannes","family":"Vey"},{"role":"aut","given":"Henrik","display":"Nienhüser, Henrik","family":"Nienhüser"},{"display":"Rompen, Ingmar F.","given":"Ingmar F.","role":"aut","family":"Rompen"},{"role":"aut","given":"Georg Martin","display":"Haag, Georg Martin","family":"Haag"},{"family":"Müller","given":"Beat P.","display":"Müller, Beat P.","role":"aut"},{"family":"Billmann","given":"Franck","display":"Billmann, Franck","role":"aut"},{"role":"aut","display":"Schmidt, Thomas","given":"Thomas","family":"Schmidt"},{"role":"aut","given":"Pascal","display":"Probst, Pascal","family":"Probst"},{"family":"Klotz","display":"Klotz, Rosa","given":"Rosa","role":"aut"},{"family":"Peters","given":"Leila","display":"Peters, Leila","role":"aut"}],"note":["Gesehen am 09.11.2024"],"origin":[{"dateIssuedDisp":"06 May 2024","dateIssuedKey":"2024"}],"relHost":[{"recId":"788288954","origin":[{"publisher":"Frontiers Media","dateIssuedDisp":"2014-","dateIssuedKey":"2014","publisherPlace":"Lausanne"}],"pubHistory":["1.2014 -"],"id":{"issn":["2296-875X"],"zdb":["2773823-1"],"eki":["788288954"]},"language":["eng"],"titleAlt":[{"title":"FSURG"},{"title":"Front. Surg."}],"title":[{"title_sort":"Frontiers in Surgery","title":"Frontiers in Surgery"}],"part":{"volume":"11","extent":"11","year":"2024","pages":"1-11","text":"11(2024) vom: 6. Mai, Artikel-ID 1382039, Seite 1-11"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Is neoadjuvant chemotherapy followed by surgery the appropriate treatment for esophagogastric signet ring cell carcinomas? a systematic review and meta-analysisFrontiers in Surgery","type":{"bibl":"periodical","media":"Online-Ressource"}}],"recId":"1908109394"} 
SRT |a SCHIEFERSAISNEOADJUV0620